STAGE III PANCREATIC CANCER
Clinical trials for STAGE III PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE III PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for STAGE III PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for Hard-to-Treat cancers
Disease control OngoingThis study tests a drug called ceralasertib, either alone or combined with olaparib or durvalumab, in people with advanced solid tumors like kidney, bladder, pancreatic, endometrial, and prostate cancers. The goal is to see if these combinations can shrink tumors or slow their gr…
Matched conditions: STAGE III PANCREATIC CANCER
Phase: PHASE2 • Sponsor: Rahul Aggarwal • Aim: Disease control
Last updated May 17, 2026 05:35 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control OngoingThis early-stage trial tests a new drug called sEphB4-HSA alongside standard chemotherapy in people with advanced or metastatic solid tumors (like head and neck, pancreatic, lung, and gallbladder cancers). The main goals are to find the best dose and check for side effects. About…
Matched conditions: STAGE III PANCREATIC CANCER
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 15, 2026 11:57 UTC